Anhui Fengyuan Pharmaceutical Co Ltd (000153) - Total Liabilities
Based on the latest financial reports, Anhui Fengyuan Pharmaceutical Co Ltd (000153) has total liabilities worth CN¥3.17 Billion CNY (≈ $463.70 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Anhui Fengyuan Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Anhui Fengyuan Pharmaceutical Co Ltd - Total Liabilities Trend (1997–2025)
This chart illustrates how Anhui Fengyuan Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Anhui Fengyuan Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Anhui Fengyuan Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Kaiwen Education Technology Co Ltd
SHE:002659
|
China | CN¥763.04 Million |
|
Banyan Gold Corp
V:BYN
|
Canada | CA$15.38 Million |
|
Henan Rebecca Hair Products Co Ltd
SHG:600439
|
China | CN¥1.91 Billion |
|
XiAn Dagang Road Machinery Co
SHE:300103
|
China | CN¥227.08 Million |
|
Hangzhou Todaytec Digital Co Ltd Class A
SHE:300743
|
China | CN¥353.32 Million |
|
Qtone Education Group Guangdong Ltd
SHE:300359
|
China | CN¥142.73 Million |
|
Dipula Income Fund Ltd
JSE:DIB
|
South Africa | ZAC4.21 Billion |
|
Foresee Pharmaceuticals Co Ltd
TWO:6576
|
Taiwan | NT$593.99 Million |
Liability Composition Analysis (1997–2025)
This chart breaks down Anhui Fengyuan Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 000153 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anhui Fengyuan Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anhui Fengyuan Pharmaceutical Co Ltd (1997–2025)
The table below shows the annual total liabilities of Anhui Fengyuan Pharmaceutical Co Ltd from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.93 Billion ≈ $429.28 Million |
+10.58% |
| 2024-12-31 | CN¥2.65 Billion ≈ $388.22 Million |
+7.30% |
| 2023-12-31 | CN¥2.47 Billion ≈ $361.80 Million |
-8.91% |
| 2022-12-31 | CN¥2.71 Billion ≈ $397.21 Million |
+20.18% |
| 2021-12-31 | CN¥2.26 Billion ≈ $330.51 Million |
+3.22% |
| 2020-12-31 | CN¥2.19 Billion ≈ $320.21 Million |
-1.98% |
| 2019-12-31 | CN¥2.23 Billion ≈ $326.68 Million |
+30.08% |
| 2018-12-31 | CN¥1.72 Billion ≈ $251.14 Million |
+10.92% |
| 2017-12-31 | CN¥1.55 Billion ≈ $226.41 Million |
+15.67% |
| 2016-12-31 | CN¥1.34 Billion ≈ $195.73 Million |
+19.32% |
| 2015-12-31 | CN¥1.12 Billion ≈ $164.04 Million |
+2.79% |
| 2014-12-31 | CN¥1.09 Billion ≈ $159.59 Million |
+17.68% |
| 2013-12-31 | CN¥926.72 Million ≈ $135.61 Million |
+37.20% |
| 2012-12-31 | CN¥675.47 Million ≈ $98.84 Million |
+22.15% |
| 2011-12-31 | CN¥552.99 Million ≈ $80.92 Million |
+5.93% |
| 2010-12-31 | CN¥522.02 Million ≈ $76.39 Million |
-0.90% |
| 2009-12-31 | CN¥526.78 Million ≈ $77.08 Million |
+2.99% |
| 2008-12-31 | CN¥511.47 Million ≈ $74.84 Million |
+13.73% |
| 2007-12-31 | CN¥449.73 Million ≈ $65.81 Million |
+1.04% |
| 2006-12-31 | CN¥445.10 Million ≈ $65.13 Million |
-9.73% |
| 2005-12-31 | CN¥493.08 Million ≈ $72.15 Million |
+61.74% |
| 2004-12-31 | CN¥304.86 Million ≈ $44.61 Million |
+89.43% |
| 2003-12-31 | CN¥160.93 Million ≈ $23.55 Million |
+30.26% |
| 2002-12-31 | CN¥123.55 Million ≈ $18.08 Million |
-28.72% |
| 2001-12-31 | CN¥173.33 Million ≈ $25.36 Million |
+69.46% |
| 2000-12-31 | CN¥102.28 Million ≈ $14.97 Million |
+25.27% |
| 1999-12-31 | CN¥81.65 Million ≈ $11.95 Million |
+23.75% |
| 1998-12-31 | CN¥65.98 Million ≈ $9.65 Million |
+89.09% |
| 1997-12-31 | CN¥34.89 Million ≈ $5.11 Million |
-- |
About Anhui Fengyuan Pharmaceutical Co Ltd
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.